Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.66 |
| ▸ | PARK7 | Q99497 | 5/20 | 0.66 |
| ▸ | ALDH2 | P05091 | 4/20 | 0.66 |
| ▸ | ALDH3A1 | P30838 | 4/20 | 0.66 |
| ▸ | CASP3 | P42574 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | CDC25A | P30304 | 9/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12930286 | 0.83 | CDC25A (0.67) | ALDH1A1PARK7ALDH2ALDH3A1CASP3 | |
| SCHEMBL16799085 | 0.80 | ALDH1A1 (1.00) | ALDH1A1PARK7ALDH2ALDH3A1CASP3 | |
| SCHEMBL12930196 | 0.79 | CDC25A (0.57) | ALDH1A1PARK7ALDH2ALDH3A1MAPT | |
| SCHEMBL1142116 | 0.77 | CASP3 (0.86) | ALDH1A1PARK7ALDH2ALDH3A1CASP3 | |
| SCHEMBL29724090 | 0.77 | CASP3 (0.86) | ALDH1A1PARK7ALDH2ALDH3A1CASP3 | |
| SCHEMBL15189265 | 0.75 | ALDH1A1 (0.52) | ALDH1A1PARK7ALDH2ALDH3A1CASP3 | |
| Dimethylamine SCHEMBL4418548 | 0.74 | CASP3 (0.75) | ALDH1A1PARK7ALDH2ALDH3A1CASP3 | |
| SCHEMBL18403869 | 0.74 | ALDH1A1 (0.53) | ALDH1A1ALDH2ALDH3A1CASP3PKM | |
| SCHEMBL2823268 | 0.73 | ALDH1A1 (0.66) | ALDH1A1PARK7ALDH2ALDH3A1CASP3 | |
| SCHEMBL13442858 | 0.71 | CASP3 (1.00) | ALDH1A1PARK7ALDH2ALDH3A1CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4662204-A2 | TELOMERASE INHIBITOR COMPOUNDS | Geron Corporation (US) | 2025-12-17 | — | — | EP | disclosed |
| US-20240343713-A1 | TELOMERASE INHIBITOR COMPOUNDS | BIOPHARMA CREDIT PLC [COLLATERAL AGENT] (GB) | 2024-10-17 | — | — | US | disclosed |
| WO-2024168165-A2 | TELOMERASE INHIBITOR COMPOUNDS | GERON CORPORATION (US) | 2024-08-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240343713-A1 | TELOMERASE INHIBITOR COMPOUNDS | TERT, POT1, TERF2 | ALDH1A1 606/4885PARK7 1931/4885ALDH2 1657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.